Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × anlotinib × CNS × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 CNS 1

Conditions

Glioma 3 Brain Neoplasms 3 Pheochromocytoma 2 Paraganglioma 2 Glioblastoma 1 Craniopharyngioma 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

fludarabine phosphate 1 anlotinib 1 aflutinib 1 Temozolomide 1 Specimen Handling 1 Radiotherapy 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Erlotinib Hydrochloride 1 Cyclophosphamide 1 Cisplatin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06483672 2024-07-03

LungBrain001

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡